The FDA’s inspection strategy became more targeted, more data-driven, and more unforgiving of systemic compliance gaps in 2025, even as the agency faced unprecedented operational challenges due partially to a government shutdown. In fact, a critical deadline arrived recently for medical device manufacturers this February. The FDA’s new Quality Management System Regulation (QMSR) is now in effect, requiring full alignment with ISO 13485:2016 standards.
This convergence of FDA challenges and newly enacted compliance requirements creates a critical moment where medical device manufacturers must assess their readiness immediately. The message is clear: the regulatory landscape has fundamentally changed, and manufacturers must ensure they’re fully compliant now that the QMSR is in force.
The Regulatory Transformation Is Here
The new QMSR has replaced the existing Quality System Regulation, aligning with ISO 13485:2016. For manufacturers who haven’t already achieved ISO 13485 certification, this represents a significant operational transformation that is no longer pending—it’s the current reality. The regulation incorporates the international standard by reference, meaning compliance with ISO 13485:2016 is now the foundation of meeting FDA requirements.
What makes this transition particularly significant is its scope. Now subject to FDA inspections, with previous exemptions removed, are:
- Management Review
- Quality Audits
- Supplier Audits
The FDA has retired its Quality System Inspection Technique (QSIT) manual in favor of an ISO-style process auditing approach that emphasizes system effectiveness and continuous improvement over checkbox compliance.
The changes extend beyond documentation. Risk management must now be integrated throughout the entire quality management system, not just limited to design and development activities. Manufacturers must demonstrate proactive risk oversight across supplier controls, manufacturing processes, post-market activities, and potential functional failures.
The New Compliance Reality
Now that the QMSR is in effect, when FDA inspections resume in full force, inspectors will apply these new standards to every facility they visit. Companies found non-compliant face serious consequences, from FDA 483 observations to warning letters and consent decrees that can halt production and delay product launches.
For manufacturers still working toward full compliance, the urgency has intensified. Organizations need to complete procedure updates, finish personnel training, validate processes, conduct internal audits, and ensure supplier compliance.
Moreover, enforcement activity accelerated sharply in 2025, with the FDA issuing warning letters at an elevated pace despite overall decreases in inspection frequency. The agency has demonstrated it will hold manufacturers to higher standards even with fewer resources, making immediate compliance verification more critical than ever.
Why ISO 13485 Certification Matters Now More Than Ever
Manufacturers who have already achieved ISO 13485 compliance are positioned to navigate this new regulatory landscape with confidence. They’ve streamlined their processes, improved product quality, and can demonstrate alignment with FDA’s current expectations. They also avoid the resource-intensive remediation work that comes from addressing non-compliance under FDA supervision.
Working with an ISO 13485-certified manufacturing partner provides essential assurance in this new regulatory environment. When external FDA oversight may be limited due to staffing challenges and recent government disruptions, partnering with suppliers who maintain robust quality management systems becomes critical for maintaining product integrity and regulatory compliance.
Immediate Action Steps for Compliance Verification
Medical device manufacturers should immediately verify their current quality management systems meet ISO 13485:2016 requirements as incorporated in the QMSR. This includes confirming that risk management processes, design controls, supplier oversight, complaint handling, and post-market surveillance procedures align with the new standards. Companies should prioritize documentation verification, particularly for records that are now subject to FDA inspection under the new regulation.
Internal auditing capabilities must be operating at full capacity to identify any gaps before FDA inspectors do. Training programs should reflect the new terminology and requirements. And critically, supplier qualification and monitoring systems must meet the heightened expectations for contractor oversight now mandated under QMSR.
Your Partner in the New Compliance Era
As the QMSR takes effect and regulatory expectations evolve, medical device manufacturers need partners who are already compliant and ready to support you through this transition. TechNH has served the medical device industry for over four decades with a proven commitment to quality and compliance. We are fully compliant with ISO 13485:2016 requirements, FDA registered, and maintain adherence to 21 CFR 820 regulations—now seamlessly aligned with the new QMSR standards.
Our expertise extends across all aspects of medical device manufacturing, from surgical components and orthopedic devices to patient monitoring systems and laboratory equipment. We provide comprehensive validation services including Installation Qualification (IQ), Operational Qualification (OQ), and Process Qualification (PQ), ensuring that every component we produce meets or exceeds regulatory requirements and medical industry standards. Our expertise across various molding resins, including polycarbonate and LCP (Liquid Crystal Polymer), ensures we can meet the diverse needs of medical device manufacturers.
When you partner with TechNH, you’re not just securing a manufacturer—you’re gaining a quality-focused ally who understands the regulatory complexities you face. Our team of seasoned engineers, dedicated project managers (all degreed engineers), and independent regulatory department work together to deliver the precision, consistency, and documentation you need to succeed in today’s demanding regulatory environment. We provide comprehensive support from initial design to production and beyond, with every client assigned a primary contact point and dedicated customer service representative.
Whether you’re verifying your QMSR compliance or need a manufacturing partner who’s already aligned with the new standards, contact TechNH today to discuss how our ISO 13485-certified manufacturing capabilities can support your regulatory goals and help bring your life-saving medical devices to market with confidence. Visit our Medical Injection Molding page or call (603) 424-4404 to learn how we can be your trusted partner in precision medical device manufacturing.